[Skip to Navigation]
Sign In
Comment & Response
November 2018

Reducing the Rate of Minimally Invasive Hysterectomy for Fibroids in Favor of Abdominal Surgery—There Is Always Something Evil in Good Intentions—Reply

Author Affiliations
  • 1Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota
  • 2Division of Gynecology and Obstetrics, Department of Surgical Sciences, University of Cagliari, Cagliari, Italy
  • 3Department of Gynecology, European Institute of Oncology (IEO), Milan, Italy
  • 4Department of Surgery, Mayo Clinic, Rochester, Minnesota
JAMA Surg. 2018;153(11):1063-1064. doi:10.1001/jamasurg.2018.2733

In Reply We thank Uccella et al for their interesting comments regarding our study1 observing a clinically significant increase of 30-day major and minor complications of hysterectomy for uterine fibroids following the US Food and Drug Administration–issued statement against the use of power morcellation. Unfortunately, the lack of data in the American College of Surgeons National Surgical Quality Improvement Program database on the prevalence of unexpected uterine sarcoma did not allow us to estimate mortality rates and surgical complications of minimally invasive hysterectomy with morcellation vs open abdominal hysterectomy.

Add or change institution